How this vulnerability can be exploited
This issue can be reached over the network, attack complexity is low, an attacker needs no privileges on the target. A user must be tricked into taking some action. The scope is unchanged, so the impact stays within the vulnerable component. Rated impact: confidentiality high, integrity high, availability high.
CVSS metrics in full
The score comes from this vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
- Attack vector: Network — reachable from anywhere that can route to the service.
- Attack complexity: Low — the attack works reliably, with no preparation.
- Privileges required: None — an unauthenticated stranger can try it.
- User interaction: Required — someone has to click, open or visit something.
- Scope: Unchanged — the damage stays inside the vulnerable component.
- Confidentiality impact: High — total loss, or loss the attacker controls.
- Integrity impact: High — total loss, or loss the attacker controls.
- Availability impact: High — total loss, or loss the attacker controls.
Weakness class
CVE-2026-24217 is classified as CWE-29: Path Traversal: '\..\filename'. The product uses external input to construct a pathname that should be within a restricted directory, but it does not properly neutralize '\..\filename' (leading backslash dot dot) sequences that can resolve to a location that is outside of that directory.
Affected software
CVE-2026-24217 is recorded against 1 package.
- bionemo-framework (fixed in 2026-04-03)
Timeline and source
Published on 20 May 2026 and last revised on 23 July 2026. No public exploit is currently recorded for this entry. Record sourced from NVD.
References
nvd.nist.gov
nvidia.custhelp.com
www.cve.org
Other advisories for this package
bionemo-framework has other advisories on record. If you are patching this one, these are worth checking on the same host:
Same weakness in other software
These advisories are the same class of weakness (CWE-29: Path Traversal: '\..\filename') in other software:
